These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10499129)

  • 1. Screening for inhibitors of dihydrofolate reductase using pulsed ultrafiltration mass spectrometry.
    Nikolic D; van Breemen RB
    Comb Chem High Throughput Screen; 1998 Apr; 1(1):47-55. PubMed ID: 10499129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization of malarial (Plasmodium falciparum) dihydrofolate reductase for the selection of tight-binding inhibitors from combinatorial library.
    Thongpanchang C; Taweechai S; Kamchonwongpaisan S; Yuthavong Y; Thebtaranonth Y
    Anal Chem; 2007 Jul; 79(13):5006-12. PubMed ID: 17530740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stoichiometric selection of tight-binding inhibitors by wild-type and mutant forms of malarial (Plasmodium falciparum) dihydrofolate reductase.
    Kamchonwongpaisan S; Vanichtanankul J; Tarnchompoo B; Yuvaniyama J; Taweechai S; Yuthavong Y
    Anal Chem; 2005 Mar; 77(5):1222-7. PubMed ID: 15732900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsed ultrafiltration mass spectrometry: a new method for screening combinatorial libraries.
    van Breemen RB; Huang CR; Nikolic D; Woodbury CP; Zhao YZ; Venton DL
    Anal Chem; 1997 Jun; 69(11):2159-64. PubMed ID: 9183179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of pulsed ultrafiltration-mass spectrometry.
    Johnson BM; Nikolic D; van Breemen RB
    Mass Spectrom Rev; 2002; 21(2):76-86. PubMed ID: 12373745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrofolate reductase from Eimeria tenella: rationalization of chemotherapeutic efficacy of pyrimethamine.
    Wang CC; Stotish RL; Poe M
    J Protozool; 1975 Nov; 22(4):564-8. PubMed ID: 1059772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry.
    Gu C; Nikolic D; Lai J; Xu X; van Breemen RB
    Comb Chem High Throughput Screen; 1999 Dec; 2(6):353-9. PubMed ID: 10644860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent analogues of methotrexate: characterization and interaction with dihydrofolate reductase.
    Kumar AA; Kempton RJ; Anstead GM; Freisheim JH
    Biochemistry; 1983 Jan; 22(2):390-5. PubMed ID: 6402009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Characterization of Dihydrofolate Reductase Complexes by Top-Down Ultraviolet Photodissociation Mass Spectrometry.
    Cammarata MB; Thyer R; Rosenberg J; Ellington A; Brodbelt JS
    J Am Chem Soc; 2015 Jul; 137(28):9128-35. PubMed ID: 26125523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the study of affinity selection-ultrafiltration/HPLC-MS].
    Zhao HY; Zhang YZ; Xiao CL
    Yao Xue Xue Bao; 2009 Oct; 44(10):1084-8. PubMed ID: 20055128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of enzyme inhibitors from phage-displayed combinatorial peptide libraries.
    Kay BK; Hamilton PT
    Comb Chem High Throughput Screen; 2001 Nov; 4(7):535-43. PubMed ID: 11562258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening drugs for metabolic stability using pulsed ultrafiltration mass spectrometry.
    Geun Shin Y; Bolton JL; van Breemen RB
    Comb Chem High Throughput Screen; 2002 Feb; 5(1):59-64. PubMed ID: 11860340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and screening of combinatorial libraries using mass spectrometry.
    Shin YG; van Breemen RB
    Biopharm Drug Dispos; 2001; 22(7-8):353-72. PubMed ID: 11835254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
    Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
    Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a micro volume pulsed ultrafiltration cell for screening ligands in non-covalent complexes.
    Beverly MB; West P; Julian RK
    Comb Chem High Throughput Screen; 2002 Feb; 5(1):65-73. PubMed ID: 11860341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical applications of affinity-ultrafiltration mass spectrometry: Recent advances and future prospects.
    Wei H; Zhang X; Tian X; Wu G
    J Pharm Biomed Anal; 2016 Nov; 131():444-453. PubMed ID: 27668554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.